Welcome to Mundipharma.
Right from the start, we are all about people and we are about patients.
The Mundipharma story, spanning over six decades, is one that brings together a visionary approach and a pioneering spirit – and is best told through our patients, our employees and the communities in which we serve. Our dedication to putting patients at the heart of every business decision has ensured that we continue to grow and more importantly, improve the lives of the people who need our medicines the most.
That foundation has not only delivered significant results, but is a reflection of our ability to convert entrepreneurism and innovation into business success.
We are focused on the transformation of Mundipharma’s business in the important Emerging Markets – by leveraging our global leadership in pain and, through a shared spirit of innovation, building a growing presence in antisepsis, respiratory, oncology, consumer healthcare and other specialty areas.
Our unique approach to partnerships has given us the opportunity to establish a strong market presence that covers the world’s pharmaceutical markets. Today we are an innovative company, with several thousand employees across the Emerging Markets serving more than four billion patients and a distribution network covering six continents. And this is just the beginning of our story in this region.
While we continue to grow and develop our business in all reaches of the globe, we also recognise that it is our people, innovation and our values that enable us to do what we do. We understand that we have a higher purpose – especially as the work we do has the ability to improve the quality of people’s lives everywhere. On a personal level, I am extremely proud to have this opportunity to lead this company and retain its focus and its core values.
Mundipharma is a company that will never lose sight of its heritage and history – and because of that, we are confident about the future as we actively pursue innovative new treatments and new opportunities in order to Bring More To Life.
Marc Princen, Global CEO